# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001842952-25-000034
Filing Date
2025-04-04
Accepted
2025-04-04 16:04:15
Documents
19
Period of Report
2025-06-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | cntx-20250404.htm iXBRL | PRE 14A | 494042
6 |  | cntx-20250404_g1.jpg | GRAPHIC | 12205
7 |  | cntx-20250404_g2.jpg | GRAPHIC | 438528
8 |  | cntx-20250404_g3.jpg | GRAPHIC | 195655
| Complete submission text file | 0001842952-25-000034.txt |  | 2330784

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cntx-20250404.xsd | EX-101.SCH | 2891
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cntx-20250404_def.xml | EX-101.DEF | 3486
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cntx-20250404_lab.xml | EX-101.LAB | 4124
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cntx-20250404_pre.xml | EX-101.PRE | 2543
21 | EXTRACTED XBRL INSTANCE DOCUMENT | cntx-20250404_htm.xml | XML | 18788

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40654 | Film No.: 25813917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)